- Trials with a EudraCT protocol (209)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
209 result(s) found for: Antiplatelet.
Displaying page 1 of 11.
| EudraCT Number: 2021-001905-66 | Sponsor Protocol Number: BA-SCAD | Start Date*: 2021-07-06 |
| Sponsor Name:Spanish Cardiology Society | ||
| Full Title: Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissection | ||
| Medical condition: Spontaneous Coronary Artery Dissection | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-000017-20 | Sponsor Protocol Number: ASS-Metamizol-DDI | Start Date*: 2018-07-17 |
| Sponsor Name:Universitäts-Herzzentrum Freiburg • Bad Krozingen | ||
| Full Title: Antiplatelet effect of acetylsalicylic acid in patients after cardiac surgery: Impact of dipyrone (metamizole) | ||
| Medical condition: Antithrombotic therapy after surgical replacement of stenotic heart valve by a bioprosthesis or mitral valve repair | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-024667-40 | Sponsor Protocol Number: PGxSTEMI08 | Start Date*: 2019-04-23 |
| Sponsor Name:St. Antonius Hospital | ||
| Full Title: Cost-effectiveness of CYP2C19 guided treatment with antiplatelet drugs in patients with ST-segment-elevation myocardial infarction undergoing immediate percutaneous coronary intervention with stent... | ||
| Medical condition: ST-segment myocardial infarction (STEMI) followed by immediate percutaneous coronary intervention with stent implantation | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-002142-50 | Sponsor Protocol Number: POPCABG03 | Start Date*: 2019-04-09 |
| Sponsor Name:St. Antonius Hospital | ||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled Trial Investigating The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery. | ||
| Medical condition: Coronary artery bypass grafting surgery with the use of one or more saphenous vein grafts. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-005149-18 | Sponsor Protocol Number: 033 | Start Date*: 2021-04-26 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: Preclinical antiplatelet treatment with Cangrelor in patients presenting with ST-Elevation myocardial infarction: a randomized, double-blind, placebo-controlled pilot trial | ||
| Medical condition: ST-Elevation Myocardial Infarction | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-001067-27 | Sponsor Protocol Number: 20604 | Start Date*: 2022-11-10 | |||||||||||||||||||||
| Sponsor Name:Bayer AG | |||||||||||||||||||||||
| Full Title: A multicenter, international, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the prevention of i... | |||||||||||||||||||||||
| Medical condition: Prevention of ischemic stroke in patients post acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: DK (Trial now transitioned) FI (Trial now transitioned) SE (Trial now transitioned) NO (Trial now transitioned) LT (Trial now transitioned) HU (Trial now transitioned) ES (Trial now transitioned) AT (Trial now transitioned) FR (Trial now transitioned) IT (Trial now transitioned) BE (Trial now transitioned) GR (Trial now transitioned) CZ (Trial now transitioned) NL (Trial now transitioned) PL (Trial now transitioned) LV (Trial now transitioned) PT (Trial now transitioned) BG (Trial now transitioned) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2018-001013-32 | Sponsor Protocol Number: CV-185-685 | Start Date*: 2018-11-08 |
| Sponsor Name:HOSPITAL CLÍNIC BARCELONA | ||
| Full Title: ANTITHROMBOTIC THERAPY AFTER LEFT ATRIAL APPENDAGE OCCLUSION: DOUBLE ANTIPLATELET THERAPY VS. APIXABAN | ||
| Medical condition: ATRIAL FIBRILLATION IN PATIENTS AFTER OCCLUSION OF THE LEFT ATRIAL APPENDAGE (LAAC) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-005042-11 | Sponsor Protocol Number: ISSBRIL0205 | Start Date*: 2014-06-11 |
| Sponsor Name:Fundación Investigación Sanitaria en León | ||
| Full Title: EndoTic ? Endothelium and Ticagrelor: Pharmacological effects beyond antiplatelet effect | ||
| Medical condition: The use of ticagrelor in ACS is related to a reduction in the number of CECs and/or an increase in the number of EPCs from the baseline values as compared with clopidogrel. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-005174-23 | Sponsor Protocol Number: CAVA2Dec04 | Start Date*: 2005-04-11 |
| Sponsor Name:NHS Grampian | ||
| Full Title: Is smooth muscle mitogenesis down regulated by platelet inactivation with combination antiplatelet therapy after angioplasty for claudication? | ||
| Medical condition: Intermittent claudication = stenosis of superficial femoral artery requiring percutaneous angioplasty | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-011907-22 | Sponsor Protocol Number: ED09/8912 | Start Date*: 2010-02-10 |
| Sponsor Name:University of Leeds | ||
| Full Title: Antiplatelet treatment in patients with diabetes mellitus: is there a difference between aspirin, clopidogrel and prasugrel | ||
| Medical condition: Type 2 diabetes mellitus | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-003190-26 | Sponsor Protocol Number: RESTART13 | Start Date*: 2013-01-14 | |||||||||||
| Sponsor Name:ACCORD (Academic and Clinical Central Office for Research & Development) [...] | |||||||||||||
| Full Title: REstart or STop Antithrombotics Randomised Trial (RESTART) | |||||||||||||
| Medical condition: Spontaneous Intracerebral Haemorrhage (ICH) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2021-006611-29 | Sponsor Protocol Number: 80009 | Start Date*: 2022-06-28 |
| Sponsor Name:University Medical Centre Utrecht Department of Vascular Surgery | ||
| Full Title: A randomized placebo-controlled double-blind trial studying the effect of antiplatelet monotherapy (clopidogrel) versus dual antiplatelet therapy (clopidogrel + aspirin) on the occurrence of athero... | ||
| Medical condition: (Chronic) Peripheral (occlusive) arterial disease (PAD) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-001093-55 | Sponsor Protocol Number: NL77315.078.21 | Start Date*: 2022-10-03 |
| Sponsor Name:Erasmus Medical center | ||
| Full Title: COATS study: genetic Clopidogrel response testing to finetune the antithrombotic regimen in (D)OAC Treated patients undergoing PCI | ||
| Medical condition: Patients on oral anticoagulation drugs who undergo a percutaneous coronary intervention (PCI) temporarily and treatment with concomitant antiplatelet therapy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-001332-11 | Sponsor Protocol Number: IRELANDPILOTV1 | Start Date*: 2014-07-30 |
| Sponsor Name:Royal College of Surgeons | ||
| Full Title: Aspirin for Optimising Pregnancy Outcome in Pregestational Diabetes: Pilot for The IRELAND Study (Investigating the Role of Early Low-dose Aspirin iN preexisting Diabetes) | ||
| Medical condition: Pregestational diabetes represents a high-risk for evolution of preeclampsia (PET), with rates of PET within this group at approximately 20%. The combination of diabetes and preeclampsia places the... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: IE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-003599-21 | Sponsor Protocol Number: MEIXO-VALV-002 | Start Date*: 2015-06-27 |
| Sponsor Name:Sociedad Española de Cardiología | ||
| Full Title: Platelet reactivity after TAVI: A multicenter randomized clinical trial | ||
| Medical condition: Study platelet reactivity in patients with Aortic Stenosis (AS) selected for TAVI and to assess the effectiviness of ticagrelor as antiplatelet monotherapy for the supression of high platelet react... | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-001904-12 | Sponsor Protocol Number: 18040 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:University of Nottingham | |||||||||||||
| Full Title: Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH) | |||||||||||||
| Medical condition: Intracerebral haemorrhage | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-000112-33 | Sponsor Protocol Number: NL47761.041.14 | Start Date*: 2014-09-01 |
| Sponsor Name:University Medical Center Utrecht | ||
| Full Title: Apixaban versus antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation. A randomised phase II clinical trial. | ||
| Medical condition: The prevention of ischaemic stroke in patients with atrial fibrillation | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-022461-10 | Sponsor Protocol Number: Final Version1 | Start Date*: 2011-02-08 |
| Sponsor Name:Southampton University Hospitals NHS Trust | ||
| Full Title: A pilot study investigating the antiplatelet effect of generic clopidogrel versus Plavix™ – is there any difference in platelet reactivity in healthy subjects? | ||
| Medical condition: The intended indication for the product is for use in all patients with acute coronary syndromes and following coronary artery stenting | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-004238-25 | Sponsor Protocol Number: 2012-004-0402-CARD | Start Date*: 2015-02-09 | |||||||||||||||||||||
| Sponsor Name:The Royal Wolverhampton NHS Trust | |||||||||||||||||||||||
| Full Title: Pharmacokinetics and Pharmacodynamics of Platelet P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction: A Pilot Study | |||||||||||||||||||||||
| Medical condition: ST-segment elevation myocardial infarction Non ST-segment elevation myocardial infarction | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2016-000195-19 | Sponsor Protocol Number: 2015CAR77 | Start Date*: 2016-03-31 | |||||||||||
| Sponsor Name:The Royal Wolverhampton NHS Trust | |||||||||||||
| Full Title: The Effect of Intravenous Cangrelor and Oral Ticagrelor on Platelets, the Microcirculation and Myocardial Damage in Patients admitted with STEMI Treated by Primary Percutaneous Coronary Interventio... | |||||||||||||
| Medical condition: Acute myocardial infarction | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
